BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19025795)

  • 1. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
    Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
    Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
    J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
    Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
    Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
    Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
    Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
    Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.
    Rousseau E; Palm T; Scaravilli F; Ruchoux MM; Figarella-Branger D; Salmon I; Ellison D; Lacroix C; Chapon F; Mikol J; Vikkula M; Godfraind C
    Mol Cancer; 2007 Jul; 6():47. PubMed ID: 17626628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
    J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of brain tumors.
    Boudreau CR; Liau LM
    Clin Neurosurg; 2004; 51():81-90. PubMed ID: 15571131
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
    Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
    Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
    Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M
    Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
    Reardon DA; Entrekin RE; Sublett J; Ragsdale S; Li H; Boyett J; Kepner JL; Look AT
    Genes Chromosomes Cancer; 1999 Mar; 24(3):230-7. PubMed ID: 10451703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
    Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
    Pezzolo A; Capra V; Raso A; Morandi F; Parodi F; Gambini C; Nozza P; Giangaspero F; Cama A; Pistoia V; Garrè ML
    Cancer Lett; 2008 Mar; 261(2):235-43. PubMed ID: 18179864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
    Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
    Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.